34 research outputs found

    Diagnostic and treatment characteristics of polycystic ovary syndrome: descriptive measurements of patient perception and awareness from 657 confidential self-reports

    Get PDF
    BACKGROUND: This investigation was undertaken to describe patient perception and awareness of the polycystic ovary syndrome (PCOS), the most common cause of anovulation/oligoovulation among women of reproductive age. METHODS: Fifteen parameters were evaluated by a computer-based research instrument accessed by a large, unscreened population. Incomplete questionnaires were not entered, and responses were electronically tabulated to block duplicate submissions. RESULTS: From 657 participants, the majority (63%) were between 26–34 years old; mean BMI was 30.4 kg/m(2). 343 of 657 had at least one pregnancy and 61% of the study group had taken fertility medicine (any type) at least once. Physicians were the most common provider of PCOS information for all study participants, irrespective of age. Patient emotions associated with the diagnosis of PCOS included "frustration" (67%), "anxiety" (16%), "sadness" (10%), and "indifference" (2%). Self-reported patient aptitude regarding PCOS was scored as high or "very aware" in >60% of women. Respondents were also asked: "If your PCOS could be safely and effectively helped by something else besides fertility drugs or birth control pills, would that interest you?" Interest in alternative PCOS treatments was expressed by 99% of the sample (n = 648). CONCLUSIONS: In our study population, most women associated negative emotions with PCOS although the self-reported knowledge level for the disorder was high. While these women regarded their obstetrician-gynecologist as integral to their PCOS education, traditional PCOS therapies based on oral contraceptives or ovulation induction agents were regarded as unsatisfactory by most women

    Sperm acrosin activity and fertilization success

    No full text
    Purpose of this study was to determine the impact of acrosine activity of ejaculated human spermatozoa on in vitro fertilization success [1]. 71 samples picked up from routine screening for infertility and for IVF-ET procedures were divided into four groups and total acrosin activity of semen samples were estimated biochemically by a method of acrosin assay [2]. Total acrosin levels were lower in subjects with oligospermia and teratospermia. The strongest positive correlation was determined between acrosin activity and fertilization rate amongst the all parameters. In conclusion, measurement of acrosin activity may be a valuable laboratory tool for assessing the sperm fertilization potential for normo and oligospermic subjects

    The influence of insulin resistance on total renin level in polycystic ovary syndrome

    No full text
    Purpose of this study is to determine the influence of insulin resistance on total renin with polycystic ovary syndrome (PCOS). Clinical, ultrasonographic and hormonal findings were used to define PCOS. Insulin resistance was estimated by the continuous infusion of glucose with model assessment (CIGMA) in early follicular phase. The sensitivity and specificity of the serum total renin level to diagnose women with PCOS were calculated as 80% and 71.4%, respectively. Serum total renin level which is independent from insulin resistance can be used as a diagnostic marker in normotensive women with PCOS

    Role of the mutations Trp(8)double right arrow Arg and Ile(15)double right arrow Thr of the human luteinizing hormone beta-subunit in women with polycystic ovary syndrome

    No full text
    Objective: To evaluate the clinical significance of LH in the form of a mutant beta-subunit in women with polycystic ovary syndrome (PCOS)

    Effect of hypertension therapy with the angiotensin-converting enzyme inhibitor lisinopril on hyperandrogenism in women with polycystic ovary syndrome

    No full text
    Objective: To investigate the effect of an angiotensin-converting enzyme inhibitor, lisinopril, on serum androgen and sex-hormone-binding globulin (SHBG) levels in hypertensive women with polycystic ovary syndrome (PCOS)

    A family presenting Goltz syndrome (focal dermal hypoplasia) in three generations

    No full text
    In this report we present three affected females of the same family in three generations. The cases have features of focal dermal hypoplasia (Goltz syndrome), One of the three affected females is the index case and the others are her mother and her grandmother. We performed skin biopsies on them. According to histopathological examinations skin lesions were compatible with Goltz syndrome. These cases exhibited focal dermal hypoplasia (FDH) manifestations including skin, dental and skeletal abnormalities. The affected females were seen in three generations of the same family which pointed to its X-linked dominance

    Granulosa cell survival and proliferation are altered in polycystic ovary syndrome

    No full text
    Context: Polycystic ovary syndrome (PCOS) represents the most common endocrine abnormality in women of reproductive age. The cause of PCOS remains largely unknown, but studies suggest an intrinsic ovarian abnormality. Objective: The objective of the study was to test our hypothesis that differences in granulosa cell proliferation and apoptosis may underlie abnormalities that affect follicular development. Design: Granulosa cells were prepared from follicular fluid aspirated from 4- to 8-mm follicles of unstimulated ovaries during routine laparoscopy or laparotomy from women with anovulatory PCOS and those with regular ovulatory cycles. Setting: The study was conducted at a university hospital. Patients: Fourteen women with anovulatory PCOS and nine women with regular ovulatory cycles participated in the study. Main Outcome Measures: Immunocytochemistry on granulosa cells to investigate apoptotic and proliferation rates, together with real-time RT-PCR to analyze gene expression profiles of apoptotic regulators, was measured. Results: Significantly lower apoptotic rates were found in granulosa cells from patients with PCOS, compared with women with regular ovulatory cycles (P = 0.004). Lower apoptotic rates were associated with decreased levels of the apoptotic effector caspase-3 (P = 0.001) and increased levels of the anti-apoptotic survival factor cellular inhibitor of apoptosis proteins-2 in the PCOS group that were coupled to higher proliferation rates (P = 0.032). Gene expression profiling confirmed the immunocytochemical findings. Conclusions: Our findings indicate that there are significant differences in the rate of cell death and proliferation in granulosa cell populations in PCOS patients. These are associated with decreased expression of apoptotic effectors and increased expression of a cell survival factor. These results provide new insights that may be useful in developing specific therapeutic intervention strategies in PCOS
    corecore